PMC

Clinical data were used to confirm that +0.2 was an acceptable certainty factor for RENEX to separate obstructed kidneys from the combined group of equivocal and non-obstructed kidneys. Kidneys considered to be equivocal or obstructed by consensus analysis were combined, and ROC curves were constructed to compare performance of RENEX with consensus interpretation with regard to distinguishing between obstructed kidneys and the combined group of nonobstructed and equivocal kidneys. ROC analysis was performed for certainty factors ranging from −1.0 to +1.0. Plot of this analysis confirms the certainty factor of +0.2 to be an acceptable threshold for separating obstructed kidneys from the combined group. Fitted ROC curve and its 95% confidence bands are shown as smooth curves. Empiric ROC curve is shown in dots.

Clinical data were used to confirm that −0.2 was an acceptable certainty factor for RENEX to separate non-obstructed kidneys from the combined group of equivocal and obstructed kidneys. Kidneys considered to be equivocal or non-obstructed by consensus analysis were combined, and ROC curves were constructed to compare performance of RENEX with consensus interpretation with regard to distinguishing between nonobstructed kidneys and the combined group of obstructed and equivocal kidneys. ROC analysis was performed for certainty factors ranging from −1.0 to +1.0. Plot of this analysis confirms the certainty factor of −0.2 to be an acceptable threshold for separating nonobstructed kidneys from the combined group. Fitted ROC curve and its 95% confidence bands are shown as smooth curves. Empiric ROC curve is shown in dots.

Display of baseline and furosemide whole-kidney renogram curves on same scale. Time–activity curve generated by pelvic ROI is also displayed on an expanded scale. Patient’s global renal function is reduced and there is diffuse retention in right kidney compatible with reduced function; however, tracer largely washed out of the right renal pelvis, and the ratio of prevoid furosemide counts to maximal counts on baseline study was only 0.26, indicating that about 75% of maximum activity had washed out of right kidney. Experts interpreted right kidney as “probably not obstructed.” RENEX also interpreted right kidney as nonobstructed (certainty factor of −0.37). Experts interpreted left kidney as “probably obstructed.” Absolute function and relative function were reduced in left kidney; there was gradual increase in tracer activity in the left renal pelvis and minimal washout after furosemide administrations. RENEX also interpreted left kidney as obstructed (certainty factor of 0.76) (Supplemental Fig. 2).

Standard display shows demographic data, dose injected, dose counted on camera, percent dose infiltrated, ^99mTc-MAG3 clearance and expected ^99mTc-MAG3 clearance followed by percent uptake, Tmax, T1/2, and 20 min/max ratios for whole-kidney ROI. Voided volume, postvoid residual, and urine flow rate were not measured. (Upper central panel) Two-second images at beginning of acquisition. (Upper right panel) Injection site; just beneath is a frame for viewing dynamic cine and pre- and postvoid bladder images. (Center panel) Twelve 2-min images followed by postvoid image of kidneys with patient lying on camera in same position as that for initial images. (Lower left panel) Whole-kidney ROIs and whole-kidney renogram curves. (Lower right panel) Cortical ROIs and cortical renogram curves. ^99mTc-MAG3 clearance was reduced (141 mL/min/1.73m² compared with normal range of 226–439 mL/min/1.73 m²). Relative uptake of left kidney was 30%. T1/2 of both kidneys was >50 min and 20 min/max ratio was bilaterally abnormal; consequently, patient received furosemide followed by a second acquisition ( and Supplemental Fig. 2).